
Read More
Large-Cap Injectable-Focused Pharma Company Gains USFDA Nod for Key Pain Ma...
With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The co...

With a PE ratio of 36.6, the company trades at a premium compared to the industry PE of 36.4. The co...